| Literature DB >> 35175820 |
Carl-Gustaf Bornehag1,2, Barbara Demeneix3, Jean-Baptiste Fini3, Chris Gennings2, Joëlle Rüegg4,5, Joachim Sturve6, Giuseppe Testa7,8,9, Nicolò Caporale7,8,9, Michelle Leemans3, Lina Birgersson6, Pierre-Luc Germain7, Cristina Cheroni7,8,9, Gábor Borbély4, Elin Engdahl4,5, Christian Lindh10, Raul Bardini Bressan11, Francesca Cavallo7, Nadav Even Chorev7, Giuseppe Alessandro D'Agostino7, Steven M Pollard11, Marco Tullio Rigoli7,8, Erika Tenderini7, Alejandro Lopez Tobon7, Sebastiano Trattaro7,8, Flavia Troglio7, Matteo Zanella7, Åke Bergman4,12,13, Pauliina Damdimopoulou4,14, Maria Jönsson5, Wieland Kiess15, Efthymia Kitraki16, Hannu Kiviranta17, Eewa Nånberg18, Mattias Öberg4,19, Panu Rantakokko17, Christina Rudén12, Olle Söder20.
Abstract
Convergent evidence associates exposure to endocrine disrupting chemicals (EDCs) with major human diseases, even at regulation-compliant concentrations. This might be because humans are exposed to EDC mixtures, whereas chemical regulation is based on a risk assessment of individual compounds. Here, we developed a mixture-centered risk assessment strategy that integrates epidemiological and experimental evidence. We identified that exposure to an EDC mixture in early pregnancy is associated with language delay in offspring. At human-relevant concentrations, this mixture disrupted hormone-regulated and disease-relevant regulatory networks in human brain organoids and in the model organisms Xenopus leavis and Danio rerio, as well as behavioral responses. Reinterrogating epidemiological data, we found that up to 54% of the children had prenatal exposures above experimentally derived levels of concern, reaching, for the upper decile compared with the lowest decile of exposure, a 3.3 times higher risk of language delay.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35175820 DOI: 10.1126/science.abe8244
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728